| Name
|
Somatostatin 28 (1-14)
|
| Other Name
|
|
| Sequence (Single letter abbreviations)
|
SANSNPAMAPRERK
|
| Sequence（Three letter abbreviations）
|
{SER}{ALA}{ASN}{SER}{ASN}{PRO}{ALA}{MET}{ALA}{PRO}{ARG}{GLU}{ARG}{LYS}
|
| Basic description
|
Somatostatin 28 arises from the posttranslational cleavage of prosomatostatin, which in turn is derived from a large precursor, preprosomatostatin. Somatostatin 28 has been found in the central and peripheral nervous system and in the gastrointestinal (GI) tract where it acts as a somatostatin receptor agonist. Som-28 can induce opposite biological effects, which suggests that Som-28, acting through distinct receptors, may function in the manner of several different neurotransmitters or neuromodulators.
|
| Solubility
|
The peptide is soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents.
|
| The molecular weight
|
1528.700
|
| Chemical formula
|
C61H105N23O21S1
|
| The purity
|
> 95%
|
| Storage conditions
|
Storage at -20°C. Keep tightly closed.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Kim DM, et al. Duodenal somatostatinoma associated with diabetic ketoacidosis presumably caused by somatostatin-28 hypersecretion. J. Clin. Endocrinol. Metab. Nov 2005; 90(11): 6310-6315.
|
Somatostatin 28 (1-14)
